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Abstract
Acetaminophen is a commonly used analgesic and has been shown to be a main cause of drug-induced liver
failure. N-acetylcysteine (NAC) should be employed as the antidote in case of acetaminophen poisoning within
the first 8-10 hours. Oral administration of NAC is universally recommended and due to the adverse effects,
the intravenous administration of the agent is reserved for patients with oral intolerance and severe complica-
tions. We here report an 18-year-old man with severe liver failure due to a huge ingestion of acetaminophen,
who was taken into the Loghman Hakim Hospital Poison Center 72 hours after attempted suicide. Regarding
the poor prognostic clues as his level of consciousness and impaired liver functions, an extensive intravenous
regimen of NAC was started. The patient survived the condition with an additional intravenous administration
of NAC past the first 72 hours of treatment. We discuss that even in late phases of intoxication; high-dose
intravenous NAC can serve a substantial improvement.
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Introduction
Acetaminophen (N-acetyl-p-aminophenol, Paraceta-
mol), a widely used over-the-counter analgesic, is a
leading cause of drug-induced acute liver failure in
western countries.1 An intake of more than 10-15 g at
one time or less in adults can be harmful. The clinical
course of acetaminophen intoxication can be divided
into four stages. In the first stage, the symptoms aremild
and laboratory findings are usually normal. Within
23 days, the serum aspartate aminotransferase (AST)
and alanine aminotransferase (ALT) rise, as do bilirubin
and prothrombin time (PT). Right upper quadrant pain
and jaundice may develop. In the third stage (72 to
96 hours after ingestion), potentially lethal hepatocellu-
lar necrosis occurs.2 Patients, who survive this period,
will start to recover over the fourth stage.
Case report
An 18-year-old man was admitted due to acetamino-
phen overdose, according to the history That was taken
from the patient’s relative, we concluded that the
patient ingested 75 tablets containing 325mg acetami-
nophen each, followed by a second intake of 30 tablets
over 24 hours (totally 34,125 mg within 24 hours). He
was admitted 48 hours after the second dose with
refractive vomiting, abdominal pain and jaundice. The
patient was lethargic. Physical examination revealed a
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general icterus and tenderness on the right upper quad-
rant of abdomen. The liver function tests are summar-
ized in Table 1. Concentrations of liver enzymes in
serum were the most in the third day of admission.
Acetaminophen was not detectable in blood.
The level of consciousness deteriorated 2 hours
after admission and he was placed under assisted ven-
tilation. Along with the supportive measures, he
received intravenous (IV) N-acetylcysteine (NAC)
in a loading dose of 140 mg/kg and then continued
in a dose of 420 mg/kg/day (70 mg/kg q4 hours daily)
for a week, and then followed by (50 mg/kg q4 hours
daily) for 5 days. During the treatment period, we
observed the patient, for adverse reaction like nausea,
vomiting, skin reaction, bronco spasm and so on. We
did not find any adverse reaction in our patient. The
fourth day, the patient showed high fever and tachyp-
nea. Bilateral pulmonary infiltrations on X-ray ima-
ging were noted. He was successfully treated with
suitable antibiotics. A high carbohydrate and low-fat
diet was begun as his mental status progressively
improved. The liver function tests and prothrombin
time (PT) returned into normal range and he left the
intensive care unit 2 weeks after admission.
The ultrasound study of liver showed a normal par-
enchyma and vasculature with the span of liver
decreased compared to the first day. However, pleural
effusion and slight ascitis were detectable by ultra-
sound assay until the 17th day. The patient was dis-
charged after a whole month of hospitalization.
Discussion
Up to 0.35% of fatalities in an Iranian tertiary
poison treatment center were due to acetaminophen
overdosage.3 We here report a case of acetaminophen
intoxication, who received his first medical care
almost 72 hours after a first ingestion of 24,375 mg
of the agent. As the patient’s general condition was
worsening at admission with signs of severe liver fail-
ure, we started a high dose IV NAC with a total
amount of almost 30,240 mg/day for a week.
Although the serum concentration of acetaminophen
was negative in this patient, it is notable that plasma
levels should be measured between 4 and 24 hours
following ingestion. A negative value does not pre-
clude a significant overdose.
Acetaminophen is mainly metabolized in liver
through conjugation with sulphate and glucoronic acid.
Around 10% of the drug is oxidized by the P450 sys-
tem to produce a highly reactive intermetabolite,
named N-acetyl-p-benzoquinoneimine (NAPQI). This
latter toxic metabolite is quickly detoxified by hepatic
glutathione (GSH) conjugations and is eliminated in
urine.4,5 When GSH hepatic storage is depleted, as in
case of acetaminophen overdose or alcohol abuse,
NAPQI binds to hepatic cell macromolecules and initi-
ates tissue necrosis.6,7 A variety of factors including
age, genetics, nutritional status and concordant drug
and substances can affect the intoxication course.2
NAC acts as a cysteine prodrug and a GSH precur-
sor. NAC is principally used to replenish the cysteine
and GSH. Also, NAC is a powerful antioxidant that
detoxifies free radicals.8,9 In addition, NAC protect
Hep33 cell from acetaminophen-induced oxidative
injury.10 NAC can be administered orally and intrave-
nously. High plasma levels of NAC may cause
adverse effects and oral administration for most cases
is effective. In patients with acute liver failure, the
IV route is recommended.11 Severe and sometimes
Table 1. Serial laboratory investigation of liver function in our patient with acetaminophen intoxication
Day 1 Day 2 Day 3 Day 4 Day 5 Day 8 Day 11
Discharge
from ICU
Discharge
from
hospital
Day 10
after
discharge
Blood sugar
(mg/mL; 70–110 mg/dL)
115 121 132 159 203 83 119 114 106 101
AST (U/L; 5–35 U/L) 700 1120 3650 1620 26 12.8 102 149 82 32
ALT (U/L; 7-56 U/L) 870 930 1150 2700 900 551 214 147 111 46
Total bilirubin (mg/dL)
normal: (0.2–1.3 mg/dL)
10.3 10.9 11.7 11.2 6.2 5.9 4.7 2.6 1.8 1.5
Alk-P (U/L; 38–126 U/L) 466 296 276 281 228 193 157 100 76 58
PT (12–14 sec) 52 41 30 23.9 24.3 23.8 15.8 13.3 13.1 14.2
INR (normal: 1) 6 5.8 4.7 3.6 3.7 2.3 1.83 1.42 1.13 0.96
AST, aspartate aminotransferase; ALT, alanine aminotransferase; Alk-P, alkaline phosphatase; PT, prothrombin time; INR, international
normalized ratio.
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life-threatening anaphylactoid reactions have been
reported after IV administration of NAC. These
adverse reactions subside rapidly when IV adminis-
tration is discontinued or decreased.12,13
NAC is indicated when the acetaminophen inges-
tion is greater than 150 mg/kg (7.5 g in adults). Use
of the NAC can provide the maximum protection
when used within the first 8 to 10 hours of an acetami-
nophen overdose.2 In this situation, the hepatotoxicity
is rare and the rate of mortality would be reduced to
less than 1%.2
In standard IV regime, the loading dose is 150mg/kg
over 15 min, followed by 50 mg/kg over the next
4 hours and 100 mg/kg over the 16 hours thereafter
(totally 300 mg/kg over 20 hours); however, higher
doses have been recommended as well.2,14 It has
been speculated that when treatment is delayed
beyond 10 hours, the oral regime may be effective
due to its larger total dose and directly delivered to
the liver.2
However, even long-term high-dose NAC inges-
tion is safe,9 IV administration of NAC has been asso-
ciated with some adverse effects,12,15 such as
urticaria, flushing, diaphoresis, pruritus and rarely
bronchospasm.16 Adverse reactions to NAC maybe
observed in 23.3% of patients.16 Despite the high fre-
quency of adverse effects, they were transient and
easily treated.12,15,16 But it is indicated in certain
patients. Having the patient under close observation
minimizes the risk of unwanted events. ‘‘Moreover,
even 72 hours after acetaminophen ingestion,’ our
patient safely received a higher IV dose of NAC. His
level of awareness improved rapidly from a deep stu-
por status and the liver function were restored com-
pletely. Late administration of NAC after 24 hours
of ingestion is still helpful and unlike the treatment
of early acetaminophen toxicity, NAC therapy should
be continued past the 72 hours standard regime, until
the patient recovers.17-20 This vigorous strategy is
notably useful for patients with progressive encepha-
lopathy and loss of consciousness. We believe that in
certain conditions, the NAC regimen must be flexibly
changed according to the condition of poisoned indi-
vidual. The adverse reactions of an IV administration
can be well monitored in an intensive care unit.
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